These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 35948941)

  • 1. Evaluation of the role of KPNA2 mutations in breast cancer prognosis using bioinformatics datasets.
    Alnoumas L; van den Driest L; Apczynski Z; Lannigan A; Johnson CH; Rattray NJW; Rattray Z
    BMC Cancer; 2022 Aug; 22(1):874. PubMed ID: 35948941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The functional role of the novel biomarker karyopherin α 2 (KPNA2) in cancer.
    Christiansen A; Dyrskjøt L
    Cancer Lett; 2013 Apr; 331(1):18-23. PubMed ID: 23268335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Karyopherin alpha 2 is a novel prognostic marker and a potential therapeutic target for colon cancer.
    Zhang Y; Zhang M; Yu F; Lu S; Sun H; Tang H; Peng Z
    J Exp Clin Cancer Res; 2015 Dec; 34():145. PubMed ID: 26626145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of karyopherin-2 in epithelial ovarian cancer and correlation with poor prognosis.
    Zheng M; Tang L; Huang L; Ding H; Liao WT; Zeng MS; Wang HY
    Obstet Gynecol; 2010 Oct; 116(4):884-891. PubMed ID: 20859152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KPNA2 is a nuclear export protein that contributes to aberrant localisation of key proteins and poor prognosis of breast cancer.
    Alshareeda AT; Negm OH; Green AR; Nolan CC; Tighe P; Albarakati N; Sultana R; Madhusudan S; Ellis IO; Rakha EA
    Br J Cancer; 2015 Jun; 112(12):1929-37. PubMed ID: 25989275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear karyopherin alpha2 expression predicts poor survival in patients with advanced breast cancer irrespective of treatment intensity.
    Gluz O; Wild P; Meiler R; Diallo-Danebrock R; Ting E; Mohrmann S; Schuett G; Dahl E; Fuchs T; Herr A; Gaumann A; Frick M; Poremba C; Nitz UA; Hartmann A
    Int J Cancer; 2008 Sep; 123(6):1433-8. PubMed ID: 18561322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of karyopherin-α2 in cholangiocarcinoma correlates with poor prognosis and gemcitabine sensitivity via nuclear translocation of DNA repair proteins.
    Tsukagoshi M; Araki K; Yokobori T; Altan B; Suzuki H; Kubo N; Watanabe A; Ishii N; Hosouchi Y; Nishiyama M; Shirabe K; Kuwano H
    Oncotarget; 2017 Jun; 8(26):42159-42172. PubMed ID: 28178675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of karyopherin 2 in human ovarian malignant germ cell tumor correlates with poor prognosis.
    He L; Ding H; Wang JH; Zhou Y; Li L; Yu YH; Huang L; Jia WH; Zeng M; Yun JP; Luo RZ; Zheng M
    PLoS One; 2012; 7(9):e42992. PubMed ID: 22962582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of overexpressed karyopherin alpha 2 with poor survival and its contribution to interleukin-1β-induced matrix metalloproteinase expression in oral cancer.
    Wang CI; Yu CJ; Huang Y; Yi JS; Cheng HW; Kao HK; Lao WW; Chang KP
    Head Neck; 2018 Aug; 40(8):1719-1733. PubMed ID: 29542209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of increased KPNA2 expression in some solid tumors: A systematic review and meta-analysis.
    Zhou LN; Tan Y; Li P; Zeng P; Chen MB; Tian Y; Zhu YQ
    Oncotarget; 2017 Jan; 8(1):303-314. PubMed ID: 27974678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of Karyopherin Alpha 2 and Karyopherin Beta 1 Correlate with Poor Prognosis in Gastric Cancer.
    Ohhara Y; Kinoshita I; Suzuki A; Imagawa M; Taguchi J; Noguchi T; Takeuchi S; Shimizu Y; Seki H; Suzuki J; Dosaka-Akita H
    Oncology; 2022; 100(12):685-695. PubMed ID: 36273446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Karyopherin Alpha 2 Is an Adverse Prognostic Factor in Clear-Cell and Papillary Renal-Cell Carcinoma.
    Müller T; Tolkach Y; Stahl D; Steiner S; Hauser S; Ellinger J; Rabien A; Ralla B; Jung K; Stephan C; Kristiansen G
    Clin Genitourin Cancer; 2019 Feb; 17(1):e167-e175. PubMed ID: 30448104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KPNA2 predicts long term survival in patients with anaplastic oligoastrocytomas.
    Gousias K; Niehusmann P; Gielen G; Simon M; Boström J
    J Clin Neurosci; 2014 Oct; 21(10):1719-24. PubMed ID: 24929863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear transport receptor karyopherin-α2 promotes malignant breast cancer phenotypes in vitro.
    Noetzel E; Rose M; Bornemann J; Gajewski M; Knüchel R; Dahl E
    Oncogene; 2012 Apr; 31(16):2101-14. PubMed ID: 21909132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear karyopherin-α2 expression in primary lesions and metastatic lymph nodes was associated with poor prognosis and progression in gastric cancer.
    Altan B; Yokobori T; Mochiki E; Ohno T; Ogata K; Ogawa A; Yanai M; Kobayashi T; Luvsandagva B; Asao T; Kuwano H
    Carcinogenesis; 2013 Oct; 34(10):2314-21. PubMed ID: 23749771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. KPNA2 is a promising biomarker candidate for esophageal squamous cell carcinoma and correlates with cell proliferation.
    Ma S; Zhao X
    Oncol Rep; 2014 Oct; 32(4):1631-7. PubMed ID: 25109899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant expression of nuclear KPNA2 is correlated with early recurrence and poor prognosis in patients with small hepatocellular carcinoma after hepatectomy.
    Jiang P; Tang Y; He L; Tang H; Liang M; Mai C; Hu L; Hong J
    Med Oncol; 2014 Aug; 31(8):131. PubMed ID: 25031071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant expression of KPNA2 is associated with a poor prognosis and contributes to OCT4 nuclear transportation in bladder cancer.
    Zhou J; Dong D; Cheng R; Wang Y; Jiang S; Zhu Y; Fan L; Mao X; Gui Y; Li Z; Li X; Shi B
    Oncotarget; 2016 Nov; 7(45):72767-72776. PubMed ID: 27611951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased expression of KPNA2 predicts unfavorable prognosis in ovarian cancer patients, possibly by targeting KIF4A signaling.
    Cui X; Wang H; Wu X; Huo K; Jing X
    J Ovarian Res; 2021 May; 14(1):71. PubMed ID: 34034774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Karyopherin α2-dependent import of E2F1 and TFDP1 maintains protumorigenic stathmin expression in liver cancer.
    Drucker E; Holzer K; Pusch S; Winkler J; Calvisi DF; Eiteneuer E; Herpel E; Goeppert B; Roessler S; Ori A; Schirmacher P; Breuhahn K; Singer S
    Cell Commun Signal; 2019 Nov; 17(1):159. PubMed ID: 31783876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.